{
  "meta": {
    "title": "Systemic_Ophthalmology_And_Tumors",
    "url": "https://brainandscalpel.vercel.app/systemic-ophthalmology-and-tumors-97f7f033.html",
    "scrapedAt": "2025-11-30T08:49:58.567Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Onchocerciasis</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Trachoma</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Schistosomiasis</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Acanthamoeba keratitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman from a rural community in sub-Saharan Africa presents with gradual vision loss over the past year. Upon examination, she exhibits conjunctival scarring, corneal opacities, and a characteristic \"pepper pot\" appearance of the conjunctiva. The patient reports a history of repeated eye infections and inadequate sanitation practices in her area. Considering the WHO's efforts to eliminate preventable causes of blindness, which of the following conditions is most likely responsible for her ocular manifestations and is a primary target for eradication?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501114aa13c12-74f3-4bfe-8112-e2e58e71a559.jpg\"></span></p>",
      "unique_key": "DT1296203",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296203,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Trachoma</strong>:\n<ul>\n<li>Cause: Caused by Chlamydia trachomatis, a bacterial infection transmitted by flies or direct contact, often due to <strong>poor hygiene and inadequate sanitation</strong>.</li>\n<li>Pathology: Repeated infections lead to <strong>chronic inflammation, conjunctival scarring, and corneal opacities</strong>, contributing to vision loss over time.</li>\n<li>Ocular Findings: <strong>\"Pepper pot\" appearance, trichiasis (inward eyelashes), corneal ulceration-all hallmarks of advanced trachoma.</strong></li>\n<li>WHO Efforts: <strong>Targeted for eradication</strong> via the <strong>SAFE strategy</strong>: Surgery, Antibiotics, Facial cleanliness, and Environmental improvements (like sanitation and clean water access).</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111cdd7be02-fb0b-4c7f-9c46-8471b3b8de3b.jpg\">\n<p><strong>Why Not Other Options?</strong></p>\n<ul>\n<li><strong>A) Onchocerciasis</strong>: Also known as river blindness, caused by Onchocerca volvulus from blackfly bites; it primarily leads to chorioretinitis and optic nerve damage, not conjunctival scarring.</li>\n<li><strong>C) Schistosomiasis</strong>: Systemic infection with rare ocular involvement, not a target for blindness eradication programs.</li>\n<li><strong>D) Acanthamoeba keratitis</strong>: Serious corneal infection, usually linked to <strong>contact lens use</strong> in unclean water, presenting with keratitis rather than chronic conjunctival or corneal changes.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Trachoma remains a leading preventable cause of blindness</strong> worldwide, especially in regions with poor sanitation.</li>\n<li>The <strong>WHO's SAFE strategy</strong> is instrumental in controlling trachoma, reducing blindness, and improving public health in impoverished communities.</li>\n</ul>",
      "correct_choice_id": 2,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked recessive</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondrial inheritance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old boy is brought to the ophthalmology clinic for evaluation of progressive vision loss and nystagmus. His parents report that he has difficulty seeing at night and has trouble with color discrimination. Family history reveals that his maternal uncle was diagnosed with retinal disorder, and his mother has mild color vision deficiency. Upon examination, the child has a characteristic \"bone spicule\" pigmentation in the retina and a visual acuity of 20/200. Genetic testing confirms a mutation in the RHO gene. Which of the following inheritance patterns is most likely associated with this condition?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111f3d5296b-da7c-45cf-9911-c6b3d8ec0f95.jpg\"></span></p>",
      "unique_key": "DT1296204",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296204,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Autosomal Dominant Retinitis Pigmentosa (RP)</strong>:\n<ul>\n<li>Genetics: RHO gene mutations commonly cause autosomal dominant RP, an inherited retinal dystrophy.</li>\n<li>Ocular Signs: Characterized by progressive <strong>night blindness, peripheral vision loss</strong>, and <strong>\"bone spicule\" pigmentation</strong> in the retina.</li>\n<li>Family History: An <strong>autosomal dominant pattern</strong> is supported by inheritance from the maternal side, affecting multiple generations.</li>\n<li>Prevalence: Often diagnosed early due to family history, enabling genetic counseling and potential therapeutic trials.</li>\n</ul>\n</li>  \n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501117ef6c8de-02bc-4ade-99c9-876ceebd6734.jpg\">\n<p><strong>Why Not Other Options?</strong></p>\n<ul>\n<li><strong>B) Autosomal recessive</strong>: Some RP cases follow this pattern, but RHO mutations are mainly linked to autosomal dominant RP.</li>\n<li><strong>C) X-linked recessive</strong>: Some retinal dystrophies (e.g., RPGR mutations) are X-linked but would not fit the maternal inheritance pattern here.</li>\n<li><strong>D) Mitochondrial inheritance</strong>: Mitochondrial conditions usually present with systemic issues alongside ocular symptoms and do not typically involve RP.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Retinitis Pigmentosa (RP)</strong> is a group of hereditary retinal disorders characterized by <strong>progressive photoreceptor degeneration</strong>.</li>\n<li>Autosomal dominant RP, often linked to RHO mutations, manifests with <strong>night blindness</strong> and <strong>visual field constriction</strong>, impacting quality of life and requiring early intervention.</li>\n</ul>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal dominant</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Autosomal recessive</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">X-linked recessive</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondrial inheritance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old girl is referred to the ophthalmology clinic due to a family history of congenital cataracts and her recent diagnosis of bilateral cataracts. The family history reveals that her mother had cataracts at an early age, and her maternal grandfather was blind from cataracts. Genetic testing confirms a mutation in the CRYAA gene. Based on this information, which of the following inheritance patterns is most likely responsible for her condition?</span></p>",
      "unique_key": "DT1296205",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296205,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Autosomal Dominant Inheritance and CRYAA Gene Mutation</strong>:</p>\n<ul>\n<li>The <strong>CRYAA gene</strong> encodes <strong>alpha-crystallin</strong>, a protein crucial for lens transparency and stability.</li>\n<li>Mutations in this gene disrupt lens structure, leading to <strong>early-onset cataracts</strong>.</li>\n<li><strong>Autosomal dominant inheritance</strong> indicates that a single copy of the mutated gene can cause the disorder, explaining why multiple family members are affected across generations.</li>\n<li><strong>Clinical Presentation of Congenital Cataracts</strong>:\n<ul>\n<li><strong>Bilateral cataracts</strong>: Often seen in congenital cases with genetic origins.</li>\n<li><strong>Progressive vision impairment</strong>: Untreated cataracts can lead to blindness, as seen in the girl&rsquo;s grandfather.</li>\n</ul>\n</li>\n<li><strong>Inheritance Pattern in Ophthalmic Genetic Disorders</strong>:</li>\n<li><strong>Autosomal Dominant</strong>: Common in conditions with a family history, like congenital cataracts and other lens or retina-related conditions.</li>\n<li><strong>Autosomal Recessive</strong>: Less likely with CRYAA mutations; requires both parents to pass down a copy of the gene.</li>\n<li><strong>X-linked and Mitochondrial Patterns</strong>: Rare in congenital cataracts related to CRYAA mutations, though some X-linked conditions, like retinoschisis, affect males predominantly.</li>\n</ul>\n<p><strong>Why Not Other Options?</strong></p>\n<ul>\n<li><strong>B) Autosomal recessive</strong>: Rare for<strong> CRYAA</strong>; commonly seen in other cataract genes (e.g., CRYBB) and typically shows sporadic family occurrence rather than across multiple generations.</li>\n<li><strong>C) X-linked recessive</strong>: Primarily affects males, with female carriers typically unaffected; doesn't match this family history.</li>\n<li><strong>D) Mitochondrial inheritance</strong>: Involves systemic issues and often multisystem involvement; isolated cataracts are uncommon.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Congenital cataracts</strong> can cause vision loss early in life; prompt <strong>diagnosis</strong> and <strong>management</strong> are critical.</li>\n<li><strong>Autosomal dominant inheritance</strong> is likely with CRYAA gene mutations, underscoring the importance of <strong>genetic counseling</strong> for families with a history of early-onset cataracts.</li>\n</ul>",
      "correct_choice_id": 21,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhage into the orbit</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct injury to the optic nerve</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Central nervous system toxicity due to anesthetic spread</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Oculocardiac reflex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 65-year-old male patient is scheduled for cataract surgery. He has a history of hypertension and diabetes mellitus but is otherwise healthy. The anesthesiologist decides to use a retrobulbar block for anesthesia. During the procedure, the patient suddenly develops a severe headache, transient visual loss, and nausea. Which of the following complications is the most likely cause of these symptoms associated with retrobulbar anesthesia?</span></p>",
      "unique_key": "DT1296206",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296206,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Central Nervous System (CNS) Toxicity from Anesthetic Spread</strong>:\n<ul>\n<li>Retrobulbar blocks are used to provide <strong>local anesthesia</strong> for eye surgeries by injecting anesthetic into the <strong>retrobulbar space</strong>.</li>\n<li>If the anesthetic agent inadvertently <strong>spreads to the CNS</strong> or is injected into a blood vessel, it can lead to <strong>acute symptoms</strong> such as:\n<ul>\n<li><strong>Severe headache</strong></li>\n<li><strong>Transient visual loss</strong></li>\n<li><strong>Nausea and other CNS symptoms</strong> like seizures or loss of consciousness in severe cases.</li>\n</ul>\n</li>\n</ul>\n</li>\n<li><strong>Differentiating Complications in Retrobulbar Block</strong>:\n<ul>\n<li><strong>Hemorrhage into the Orbit</strong>: Can cause <strong>proptosis, pain, and decreased vision</strong> but typically lacks the severe headache and nausea seen in CNS toxicity.</li>\n<li><strong>Optic Nerve Injury</strong>: May lead to <strong>vision disturbances</strong> but does not usually result in headache or nausea as primary symptoms.</li>\n<li><strong>Oculocardiac Reflex</strong>: Induces <strong>bradycardia</strong> due to pressure on the eyeball or extraocular muscles; does not typically cause headache or nausea.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Ocular Anesthesia:</strong></p>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501118bb07af8-a71f-4121-84cf-79a87cdb0dcb.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111ba15bdea-b08e-468a-b4c6-76ea45b9ad9a.jpg\">\n<p><strong>Why Not Other Options?</strong></p>\n<ul>\n<li><strong>A) Hemorrhage into the orbit</strong>: Presents with proptosis and pain, with headache and nausea less prominent.</li>\n<li><strong>B) Direct injury to the optic nerve</strong>: Causes visual disturbances; however, headache and nausea are uncommon.</li>\n<li><strong>D) Oculocardiac reflex</strong>: Causes bradycardia and syncope, not headache or nausea.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Retrobulbar blocks</strong> are effective for <strong>ocular anesthesia</strong> but can lead to CNS toxicity if anesthetic spreads to the brainstem or CNS.</li>\n<li><strong>Symptoms</strong> of CNS spread include <strong>headache, nausea, visual loss, and potential seizures</strong>.</li>\n<li><strong>Monitoring and prompt management</strong> are crucial to address any adverse reactions during anesthesia.</li>\n</ul>",
      "correct_choice_id": 33,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Uniform distribution of fluorescein across the cornea</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Bright green staining in the area of the corneal epithelium</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">Absence of fluorescein staining in a specific area of the cornea</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Staining of the conjunctiva with fluorescein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old woman presents to the emergency department with complaints of acute onset of redness, pain, and tearing in her right eye after she accidentally splashed household cleaning solution into it. On examination, the eye is hyperemic, and she exhibits blepharospasm. To evaluate for corneal injury, the ophthalmologist performs a fluorescein stain test. Which of the following findings is most indicative of a corneal epithelial defect during this procedure?</span></p>",
      "unique_key": "DT1296208",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296208,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Absence of Fluorescein Staining in Corneal Defects:</strong>\n<ul>\n<li>Fluorescein stain is used to evaluate <strong>corneal integrity</strong>. When applied, it adheres to <strong>damaged epithelial areas</strong>, creating a <strong>bright green stain</strong> under cobalt blue light.</li>\n<li><strong>Absence of staining</strong> in specific areas indicates an <strong>epithelial defect</strong>, suggesting a <strong>corneal abrasion or injury</strong>.</li>\n<li>In this patient with chemical exposure, the test can reveal <strong>corneal epithelial damage</strong>, guiding management.</li>\n</ul>\n</li>\n<li><strong>Interpretation of Other Findings</strong>:\n<ul>\n<li><strong>Uniform Fluorescein Distribution</strong>: Seen in a healthy cornea with intact epithelium, indicating no injury.</li>\n<li><strong>Bright Green Staining</strong>: Commonly observed in intact areas and does not imply a defect; injured areas may lack uptake.</li>\n<li><strong>Conjunctival Staining</strong>: Reflects conjunctival issues but <strong>does not confirm corneal epithelial defects</strong>.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Fluorescein Stain in Ophthalmology:</strong> A vital diagnostic tool used to evaluate the integrity of the corneal epithelium, assess tear film stability, and identify foreign bodies or abrasions.</p>\n<ul>\n<li><strong>Indications:</strong>\n<ul>\n<li><strong>Corneal Abrasions:</strong> Absence of staining indicates epithelial defects, corneal ulcers.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011107839d6a-2e52-492d-a17d-ebd1f58abdd4.jpg\">\n</li>\n<li><strong>Dry Eye Evaluation:</strong> Staining patterns can help assess tear film stability.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011132b49d31-4195-4b46-9440-dbd2dca65a8e.jpg\">\n</li>\n<li><strong>Foreign Body Detection:</strong> Fluorescein can highlight areas of epithelial disruption.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501119e1e399f-29c7-4526-b687-42c03015bc3b.jpg\">\n</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>Technique:</strong>\n<ul>\n<li><strong>Application:</strong> Fluorescein dye can be applied topically as a strip or in solution. <strong>Observation under cobalt blue light enhances visibility of staining patterns</strong>.</li>\n</ul>\n</li>\n<li><strong>Interpretation of Findings:</strong> Understanding the implications of fluorescein staining is crucial in diagnosing and managing various ocular surface disorders.</li>\n</ul>\n<p><strong>Why Not Other Options?</strong></p>\n<ul>\n<li><strong>A) Uniform distribution of fluorescein across the cornea</strong>: Indicates a healthy corneal surface without defects.</li>\n<li><strong>B) Bright green staining in the area of the corneal epithelium</strong>: Normal staining response, not necessarily indicative of injury.</li>\n<li><strong>D) Staining of the conjunctiva with fluorescein</strong>: May occur in conjunctival issues but is unrelated to corneal epithelial defects.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Fluorescein staining</strong> is essential for diagnosing corneal epithelial defects, abrasions, or foreign bodies.</li>\n<li><strong>Absence of fluorescein staining</strong> in a specific area suggests a <strong>corneal epithelial defect</strong>, guiding appropriate management.</li>\n</ul>",
      "correct_choice_id": 43,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Schirmer test results of > 15 mm at 5 minutes</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Schirmer test results of 10-15 mm at 5 minutes</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Schirmer test results of < 10 mm at 5 minutes</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Schirmer test results of < 5 mm at 5 minutes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old woman presents to the clinic with complaints of dryness, grittiness, and intermittent blurry vision in both eyes. She has a history of rheumatoid arthritis and is concerned that her symptoms may be related to her condition. The ophthalmologist performs a Schirmer test to evaluate her tear production. Which of the following results on the Schirmer test is most indicative of a diagnosis of Sjogren's syndrome?</span></p>",
      "unique_key": "DT1296211",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296211,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong>Schirmer Test and Sj&ouml;gren's Syndrome</strong>:</p>\n<ul>\n<li>The <strong>Schirmer test</strong> is used to assess <strong>tear production</strong> by placing filter paper in the lower conjunctival sac for 5 minutes.</li>\n<li><strong>&lt; 10 mm wetting</strong> on the Schirmer test suggests <strong>significant tear deficiency</strong> associated with <strong>Sj&ouml;gren's syndrome or severe dry eye disease</strong>.</li>\n<li>Sj&ouml;gren's syndrome commonly presents with <strong>reduced tear and saliva production</strong>, causing dryness, particularly in those with autoimmune conditions like <strong>rheumatoid arthritis</strong>.</li>\n<li><strong>Interpretation of Other Results</strong>:</li>\n<li><strong>&gt; 15 mm</strong>: Indicates normal tear production, excluding Sj&ouml;gren's-related dry eye.</li>\n<li><strong>10-15 mm</strong>: Suggests mild to moderate dry eye but not typically diagnostic of Sj&ouml;gren's.</li>\n<li><strong>&lt; 5 mm</strong>: Indicates severe tear deficiency but can be seen in various dry eye conditions, not exclusively Sj&ouml;gren's.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501111af34bbf-d358-428f-9df8-283da7f4521a.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501118784e302-cf1e-422b-8af2-9535ebfd4eb7.jpg\">\n<p><strong>Why Not Other Options?</strong></p>\n<ul>\n<li><strong>A) Schirmer test results of &gt; 15 mm at 5 minutes</strong>: Suggests normal tear production, not associated with Sj&ouml;gren's.</li>\n<li><strong>B) Schirmer test results of 10-15 mm at 5 minutes</strong>: May indicate mild dryness but lacks specificity for Sj&ouml;gren's.</li>\n<li><strong>D) Schirmer test results of &lt; 5 mm at 5 minutes</strong>: Shows severe tear deficiency; however, &lt; 10 mm is a more typical threshold for Sj&ouml;gren's diagnosis.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Schirmer test</strong> measures tear production, aiding in the diagnosis of <strong>dry eye syndromes</strong> like Sj&ouml;gren's.</li>\n<li>A result of <strong>&lt; 10 mm</strong> suggests <strong>significant tear deficiency</strong>, common in <strong>autoimmune-related dry eye diseases</strong>.</li>\n<li>Recognizing <strong>dry eye in autoimmune conditions</strong> is essential for targeted management, including <strong>tear substitutes</strong> and <strong>immunomodulatory treatments</strong>.</li>\n</ul>",
      "correct_choice_id": 53,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">Tritanopia</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">Deuteranopia</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">Protanopia</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">Achromatopsia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old man presents to the ophthalmology clinic for a vision assessment before applying for a pilot license. He reports difficulty distinguishing between certain colors, particularly reds and greens, but has normal visual acuity. Family history reveals that his maternal uncle also had similar difficulties. Based on this information, which of the following types of color vision deficiency is he most likely experiencing?</span></p>",
      "unique_key": "DT1296212",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296212,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Protanopia</strong>:\n<ul>\n<li>Protanopia is characterized by the <strong>absence of red cones (L-cones)</strong>, leading to difficulty distinguishing <strong>red from green</strong>.</li>\n<li>The <strong>X-linked recessive inheritance</strong> pattern explains the family history, as males are more commonly affected, and maternal male relatives may also exhibit similar issues.</li>\n<li>Common symptoms include <strong>normal visual acuity with specific red-green discrimination difficulty</strong>, aligning with the patient's presentation.</li>\n</ul>\n</li>\n<li><strong>Differentiating from Other Options</strong>:\n<ul>\n<li><strong>Tritanopia</strong> affects <strong>blue-yellow discrimination</strong> and is rarer, with no difficulty in red-green distinction.</li>\n<li><strong>Deuteranopia</strong> is also a red-green deficiency due to the <strong>absence of green cones (M-cones)</strong>, but given the specific report of trouble with reds, protanopia is more likely.</li>\n<li><strong>Achromatopsia</strong> is a complete absence of color vision, generally accompanied by other visual issues like <strong>photophobia and nystagmus</strong>, which this patient lacks.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111cb645e43-b6f7-4ace-b47e-5355ac986053.jpg\">\n<p><strong>Why Not Other Options?</strong></p>\n<ul>\n<li><strong>A) Tritanopia</strong>: Causes blue-yellow confusion, not red-green.</li>\n<li><strong>B) Deuteranopia</strong>: Involves green cone deficiency and can also cause red-green confusion, but the specific difficulty with red suggests protanopia.</li>\n<li><strong>D) Achromatopsia</strong>: Leads to total color blindness and additional symptoms, which are not seen here.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Color blindness</strong> primarily affects <strong>color perception</strong> due to <strong>cone photopigment deficiencies</strong>.</li>\n<li><strong>Protanopia</strong> (red cone absence) and <strong>deuteranopia</strong> (green cone absence) are the most common forms of red-green color blindness and follow <strong>X-linked recessive inheritance</strong>, impacting males more frequently.</li>\n<li><strong>Color vision testing</strong> (like <strong>Ishihara plates</strong>) helps confirm the type and severity of color vision deficiency.</li>\n</ul>",
      "correct_choice_id": 63,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal vein occlusion</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Uveitis</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Conjunctivitis</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Keratitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old male patient presents to the ophthalmology clinic with complaints of redness and irritation in both eyes for the past week. He recently recovered from a mild case of COVID-19, which he contracted three weeks ago. On examination, the patient exhibits conjunctival hyperemia, chemosis, and watery discharge. Which of the following ocular manifestations is most commonly associated with COVID-19?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111e8e1f18c-0020-4cd1-b6bc-39169d6fb146.jpg\"></span></p>",
      "unique_key": "DT1296214",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296214,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Conjunctivitis</strong>:\n<ul>\n<li>Conjunctivitis is the <strong>most frequently reported ocular manifestation of COVID-19</strong> and can appear as <strong>conjunctival hyperemia, chemosis, and watery discharge</strong>.</li>\n<li>COVID-19-related conjunctivitis typically presents as <strong>mild follicular conjunctivitis</strong> but can also include <strong>bulbar injection</strong> and, in severe cases, <strong>hemorrhagic conjunctivitis or pseudomembrane formation</strong>.</li>\n</ul>\n</li>\n<li><strong>Differentiating from Other Options</strong>:\n<ul>\n<li><strong>Retinal vein occlusion</strong> can occur in severe COVID-19 cases due to vascular issues but is not commonly seen.</li>\n<li><strong>Uveitis</strong> has been reported with COVID-19, especially in cases with multisystem inflammatory disease, but it is less common than conjunctivitis.</li>\n<li><strong>Keratitis</strong> can occur due to viral infections but is not specifically associated with COVID-19.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Other Options?</strong></p>\n<ul>\n<li><strong>A) Retinal vein occlusion</strong>: Linked to vascular complications but is uncommon and typically seen in systemic cases.</li>\n<li><strong>B) Uveitis</strong>: Possible in COVID-19 but not a primary manifestation.</li>\n<li><strong>D) Keratitis</strong>: Rarely reported in association with COVID-19 and less common than conjunctivitis.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>COVID-19 Conjunctivitis</strong>: Often mild, with signs like <strong>redness, watery discharge, and chemosis</strong>.</li>\n<li><strong>Less Common Ocular Findings</strong>: COVID-19 can rarely cause vascular issues (e.g., retinal vein occlusion), uveitis, or optic nerve involvement.</li>\n<li><strong>COVID-19 Ocular Presentation</strong>: Conjunctivitis remains the primary ocular symptom, aiding in early detection and supportive care.</li>\n</ul>\n<p><strong>Reference: </strong> Hu K, Patel J, Swiston C, et al. Ophthalmic Manifestations of Coronavirus (COVID-19) [Updated 2024 May 6]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556093</p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Focusing exclusively on cataract surgery in urban areas</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Establishing community-based eye care services and awareness programs</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Providing free spectacles to all individuals regardless of need</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Developing advanced surgical techniques for retinal diseases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A public health ophthalmologist is developing a strategy to implement the Vision 2020 initiative in a developing country where the prevalence of avoidable blindness is high. The program aims to reduce blindness caused by the leading causes of visual impairment. Which of the following strategies is most aligned with the goals of Vision 2020?</span></p>",
      "unique_key": "DT1296216",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296216,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Community-Based Eye Care Services</strong>:\n<ul>\n<li><strong>Accessibility</strong>: Establishing services in underserved areas ensures that individuals have access to essential eye care, particularly in rural communities.</li>\n<li><strong>Preventive Care</strong>: Focus on screening programs for early detection of eye diseases, which can significantly reduce the incidence of blindness.</li>\n<li><strong>Health Education</strong>: Raising awareness about common eye conditions and the importance of seeking treatment helps empower communities to take charge of their eye health.</li>\n<li><strong>Integration with Local Health Systems</strong>: Collaborating with existing health infrastructure to provide comprehensive health services, thus leveraging available resources.</li>\n</ul>\n</li>\n<li><strong>Why not other Other :</strong>\n<ul>\n<li><strong>A) Focusing exclusively on cataract surgery in urban areas</strong>:\n<ul>\n<li><strong>Limited Reach</strong>: Ignores the significant need for services in rural populations where access is often restricted.</li>\n<li><strong>Neglects Other Causes</strong>: Concentrating solely on cataracts overlooks other major causes of blindness such as glaucoma, diabetic retinopathy, and refractive errors.</li>\n</ul>\n</li>\n<li><strong>C) Providing free spectacles to all individuals regardless of need</strong>:\n<ul>\n<li><strong>Resource Allocation</strong>: May lead to misallocation of resources, as not everyone requires spectacles, and the underlying causes of visual impairment might remain unaddressed.</li>\n<li><strong>Sustainability Issues</strong>: Free distribution without assessment can lead to a lack of ongoing support for eye health initiatives.</li>\n</ul>\n</li>\n<li><strong>D) Developing advanced surgical techniques for retinal diseases</strong>:\n<ul>\n<li><strong>Specialized Focus</strong>: While valuable, this approach caters to a small subset of the population and does not address the broader spectrum of visual impairments prevalent in developing countries.</li>\n<li><strong>Training and Resources</strong>: Requires specialized training and equipment, which may not be feasible in resource-limited settings.</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>Vision 2020 Initiative</strong>: A global effort to eliminate avoidable blindness through accessible eye care and community engagement.</li>\n<li><strong>Holistic Approach</strong>: A focus on comprehensive eye care that includes prevention, treatment, and education is essential to address the complex issues surrounding visual impairment.</li>\n<li><strong>Community Empowerment</strong>: Involving local communities in the planning and execution of eye care services enhances effectiveness and sustainability.</li>\n</ul>\n<p><strong>Reference:</strong> WHO official guidelines for Vision 2020</p>",
      "correct_choice_id": 82,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Increase the production of affordable contact lenses worldwide</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Achieve a 40% increase in the proportion of people with access to appropriate spectacles</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduce the global prevalence of cataracts by 40%</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Establish WHO-led eye care centers in every country</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The World Health Organization (WHO) has launched the SPECS 2030 initiative to address uncorrected refractive errors globally. What is the primary goal of the SPECS 2030 initiative?</span></p>",
      "unique_key": "DT1296218",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296218,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li>The WHO's <strong>SPECS 2030 initiative</strong> targets a <strong>40% increase</strong> in access to appropriate spectacles.</li>\n<li>Aims to mitigate vision impairment caused by <strong>uncorrected refractive errors</strong> like <strong>myopia</strong> (short-sightedness) and <strong>hyperopia</strong> (long-sightedness).</li>\n<li>Focuses on <strong>5 key pillars</strong>:\n<ul>\n<li><strong>Improve access to refractive services:</strong> Ensuring services are available in both urban and rural areas.</li>\n<li><strong>Build personnel capacity:</strong> Training healthcare providers in vision assessment and spectacle provision.</li>\n<li><strong>Enhance population education:</strong> Increasing awareness about the importance of vision correction and regular eye examinations.</li>\n<li><strong>Reduce service costs:</strong> Making spectacles and services more affordable to a broader population.</li>\n<li><strong>Strengthen surveillance and research:</strong> Monitoring the prevalence of refractive errors and the effectiveness of interventions.</li>\n</ul>\n</li>\n<li><strong>Four key strategies</strong> for engagement:\n<ul>\n<li><strong>Normative work:</strong> Leveraging existing WHO guidelines to develop new resources and best practices.</li>\n<li><strong>Global SPECS Network:</strong> Creating a collaborative platform for organizations to share experiences and advocate for better eye care.</li>\n<li><strong>Private sector dialogues:</strong> Engaging with industries such as optical and pharmaceutical to foster partnerships and innovation.</li>\n<li><strong>Regional and country engagement:</strong> Implementing tailored activities to enhance local capacities and bridge gaps in eye care services.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Others:</strong></p>\n<ul>\n<li>A. Increasing affordable contact lenses does not directly address the issue of refractive errors treated with spectacles.</li>\n<li>C. The focus of the initiative is on refractive errors rather than cataracts, which are a separate concern in eye health.</li>\n<li>D. Establishing WHO-led eye care centers is not part of the SPECS 2030 goals; the initiative emphasizes access to spectacles rather than institutional setups.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li><strong>SPECS 2030</strong> aims for a <strong>40% increase</strong> in access to spectacles, directly addressing refractive errors.</li>\n<li>Focuses on reducing <strong>vision impairment</strong> and enhancing global eye care access.</li>\n<li>The initiative includes strategic engagement with <strong>stakeholders</strong>, emphasizing <strong>collaboration</strong> across various sectors for sustainable solutions.</li>\n</ul>\n<p><strong>Reference:</strong> WHO official site, health department update, 14th may 2024, The SPECS 2030 initiative</p>",
      "correct_choice_id": 92,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Marfan syndrome</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Stickler syndrome</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Ehlers-Danlos syndrome</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteogenesis imperfecta</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy is brought to the ophthalmology clinic for evaluation of blurred vision and progressive myopia. On examination, the child exhibits high myopia, vitreous opacities, and a characteristic stretched appearance of the globe. His family history reveals that his mother has similar ocular symptoms, along with joint problems. Based on these findings, which of the following conditions is the child most likely affected by?</span></p>",
      "unique_key": "DT1296221",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296221,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>Stickler Syndrome</u></strong><strong>:</strong></p>\n<ul>\n<li>A connective tissue disorder caused by mutations in genes encoding collagen, primarily COL2A1, leading to various ocular, musculoskeletal, and auditory abnormalities.</li>\n<li><strong>High Myopia:</strong> A hallmark of Stickler syndrome; significant nearsightedness often requiring corrective lenses.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011133c8e3f7-6f47-4815-9f39-eea2c897c7b2.jpg\">\n</li>\n<li><strong>Vitreous Opacities:</strong> Patients may experience floaters due to degeneration of the vitreous body; a characteristic beaded appearance can occur.</li>\n<li><strong>Stretched Globe Appearance:</strong> This is indicative of globe elongation seen in conditions like Stickler syndrome due to the structural changes in the eye.</li>\n<li><strong>Family History:</strong> Suggests an <strong>autosomal dominant inheritance</strong> pattern, common in Stickler syndrome, reinforcing the likelihood of genetic predisposition.</li>\n<li><strong>Joint Problems:</strong> Patients often present with joint hypermobility, early-onset osteoarthritis, and may have a history of joint pain or instability.</li>\n<li><strong>Facial Features:</strong> Characteristic flat midface and underdevelopment can contribute to distinct facial features; associated conditions may include cleft palate or Pierre Robin sequence.</li>\n<li><strong>Auditory Implications:</strong> Patients may also experience hearing loss, which can be conductive or sensorineural, adding to the complexity of the syndrome.</li>\n<li><strong>Risk of Retinal Detachment:</strong> The structural changes in the eye increase the risk of retinal tears and detachment, necessitating regular monitoring by an eye care professional.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111f25871c2-a146-46a4-a395-ffd4f02f7265.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111c7de4542-0f95-4807-92e2-6f9ba7911979.jpg\">\n<p><strong>Why Not Others:</strong></p>\n<ul>\n<li><strong>A) Marfan syndrome:</strong> While it includes ocular findings like lens dislocation, it lacks the specific vitreous abnormalities and high myopia seen in Stickler syndrome.</li>\n<li><strong>C) Ehlers-Danlos syndrome:</strong> Although it can present with myopia and corneal thinning, it primarily features skin hyperelasticity and is less associated with the vitreous changes specific to Stickler syndrome.</li>\n<li><strong>D) Osteogenesis imperfecta:</strong> Primarily affects bone integrity with characteristics such as frequent fractures and blue sclerae; it does not typically involve high myopia or vitreous degeneration.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<ul>\n<li>Stickler syndrome is a connective tissue disorder marked by <strong>ocular and systemic manifestations, including high myopia and joint issues.</strong></li>\n<li>It follows an <strong>autosomal dominant inheritance</strong> pattern, which is important for family history assessment.</li>\n<li>Regular eye examinations are crucial for early detection of complications like retinal detachment and to manage associated systemic issues effectively.</li>\n<li>Understanding the multi-faceted implications of Stickler syndrome can guide comprehensive management strategies for affected individuals.</li>\n</ul>",
      "correct_choice_id": 102,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinitis pigmentosa</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Goldmann-Favre syndrome</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Usher syndrome</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Choroideremia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old girl presents to the ophthalmology clinic with complaints of night blindness and progressive vision loss over the past year. On examination, she demonstrates a significant reduction in visual acuity and a characteristic \"bone-spicule\" pigmentation in the fundus. The patient also has a family history of similar ocular problems. Genetic testing reveals a mutation in the EYS gene. Based on these findings, what is the most likely diagnosis?</span></p>",
      "unique_key": "DT1296222",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296222,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>Goldmann-Favre Syndrome:</u></strong></p>\n<ul>\n<li>A rare inherited retinal dystrophy characterized by a combination of retinitis pigmentosa-like symptoms and cystic changes in the macula.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111dace918f-37d4-4c14-ac92-a87d40b1ccdf.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111b1206180-cd6c-4927-b31f-0ac05170bf31.jpg\">\n<p><strong>Key Features:</strong></p>\n<ul>\n<li><strong>Night Blindness:</strong> Early symptom due to rod photoreceptor degeneration.</li>\n<li><strong>Visual Acuity Loss:</strong> Progresses with age; can be profound.</li>\n<li><strong>Fundoscopic Findings:</strong> Characteristic bone-spicule pigmentation in the mid-periphery of the retina and cystic macular changes.</li>\n</ul>\n<ul>\n<li><strong>Genetics:</strong> Associated with mutations in the <strong>EYS</strong> gene, which plays a role in photoreceptor function and stability.</li>\n<li><strong>Inheritance Pattern:</strong> Typically inherited in an <strong>autosomal recessive</strong> manner, although some cases may have an autosomal dominant pattern.</li>\n</ul>\n<p><strong>Why Not Other Options:</strong></p>\n<ul>\n<li><strong>A) Retinitis pigmentosa:</strong> Shares similar fundoscopic findings but lacks the macular cystic changes and specific genetic association (EYS mutation) linked to Goldmann-Favre syndrome.</li>\n<li><strong>C) Usher syndrome:</strong> Involves retinitis pigmentosa with <strong>hearing loss</strong>, which is not seen in this patient.</li>\n<li><strong>D) Choroideremia:</strong> Primarily affects males and leads to choroidal atrophy without bone-spicule pigmentation, typically due to <strong>CHM gene mutation</strong>.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p>Goldmann-Favre syndrome is a rare retinal dystrophy marked by <strong>night blindness, visual acuity loss, bone-spicule pigmentation, and macular cystic changes-</strong>often tied to <strong>EYS gene mutations</strong>.</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Apert syndrome</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Treacher Collins syndrome</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Crouzon syndrome</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Goldenhar syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old boy is brought to the ophthalmology clinic for evaluation of his vision. The child has distinct facial features, including hypoplasia of the zygomatic bones and downward slanting palpebral fissures. On examination, he is noted to have a low-set hairline, malformations of the external ears, and significant refractive error. Family history reveals no similar conditions. Based on the clinical findings, what is the most likely diagnosis?</span></p>",
      "unique_key": "DT1296223",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296223,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<p><strong><u>Treacher Collins Syndrome:</u></strong></p>\n<ul>\n<li>A genetic disorder caused by mutations in the <strong>TCOF1</strong>, <strong>POLR1C</strong>, or <strong>POLR1D</strong> genes, leading to abnormal development of the bones and tissues in the face.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111eed6e18d-31e3-49bb-bebe-dd5e7b0f2d5c.jpg\">\n<ul>\n<li><strong>Key Features:</strong>\n<ul>\n<li><strong>Craniofacial Anomalies:</strong> Hypoplasia of the zygomatic bones, mandible, and maxilla; downward-slanting palpebral fissures; and low-set ears.</li>\n<li><strong>Ocular Manifestations:</strong> Patients may have eyelid malformations (e.g., lower eyelid colobomas) and refractive errors. They are at risk for amblyopia due to strabismus.</li>\n<li><strong>Hearing Loss:</strong> Conductive hearing loss due to middle ear malformations is common.</li>\n</ul>\n</li>\n<li><strong>Inheritance Pattern:</strong> Treacher Collins syndrome typically follows an <strong>autosomal dominant</strong> inheritance pattern, though some cases arise from new mutations.</li>\n</ul>\n<p><strong>Why Not Other Options:</strong></p>\n<ul>\n<li><strong>A) Apert syndrome:</strong> Associated with <strong>craniosynostosis and syndactyly</strong>; lacks the specific facial features like zygomatic hypoplasia found in Treacher Collins syndrome.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111a06667bd-023a-4bc5-8fc7-ff7516a62c29.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111bf242494-eb16-49bc-928b-83fddbd2abdf.jpg\"></li>\n<li><strong>C) Crouzon syndrome:</strong> Involves <strong>craniosynostosis</strong> with proptosis, but facial features differ significantly.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111bcaa13d9-ef49-42d9-b714-e881998e81e6.jpg\">\n</li>\n<li><strong>D) Goldenhar syndrome:</strong> Features <strong>hemifacial microsomia</strong> and vertebral anomalies, with a distinct pattern from Treacher Collins syndrome.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p>Treacher Collins syndrome is a genetic disorder marked by <strong>distinct craniofacial anomalies (hypoplastic zygomatic bones, low-set ears)</strong>, often leading to <strong>refractive errors and conductive hearing loss</strong> due to middle ear malformations.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Treacher Collins syndrome</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">Goldenhar syndrome</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Crouzon syndrome</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Apert syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 7-year-old girl is brought to the ophthalmology clinic for evaluation of her vision. She was born with facial asymmetry and ear abnormalities, and her parents report that she has had intermittent episodes of blurred vision. On examination, the child exhibits a right-sided microtia, coloboma of the right lower eyelid, and a prominent epicanthic fold. There are also signs of vertebral anomalies noted on imaging. Which of the following conditions is most consistent with this clinical presentation?</span></p>",
      "unique_key": "DT1296224",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296224,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Goldenhar Syndrome</strong> (Oculo-Auriculo-Vertebral Spectrum) is marked by <strong>facial asymmetry, ear abnormalities (e.g., microtia), ocular defects (such as coloboma)</strong>, and <strong>vertebral anomalies</strong>.</li>\n<li><strong>Key Features:</strong>\n<ul>\n<li><strong>Ear Malformations:</strong> Microtia or anotia, often unilateral</li>\n<li><strong>Ocular Defects:</strong> Colobomas, epibulbar dermoids</li>\n<li><strong>Vertebral Anomalies:</strong> Hemivertebrae, fusion anomalies</li>\n</ul>\n</li>  \n<li><strong>Etiology:</strong> Likely due to disruptions in <strong>embryonic development affecting the first and second pharyngeal arches.</strong></li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111787cc24d-46f4-4293-b0bb-4234eae52e9d.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501112ce43796-abe3-4906-8318-c4544f95fff7.jpg\">\n<p><strong>Why Not Other Options:</strong></p>\n<ul>\n<li><strong>A) Treacher Collins syndrome:</strong> Involves <strong>facial dysostosis</strong> with zygomatic hypoplasia, lacks vertebral anomalies typical in Goldenhar syndrome.</li>\n<li><strong>C) Crouzon syndrome:</strong> Characterized by <strong>craniosynostosis</strong> and proptosis but lacks ear and vertebral anomalies.</li>\n<li><strong>D) Apert syndrome:</strong> Known for <strong>craniosynostosis and syndactyly</strong>, not associated with ear and vertebral anomalies specific to Goldenhar syndrome.</li>\n</ul>\n<p><strong>Key Takeaways:</strong><br /> Goldenhar syndrome, also known as <strong>Oculo-Auriculo-Vertebral Spectrum</strong>, typically presents with <strong>facial asymmetry, ear malformations, ocular defects, and vertebral anomalies</strong>, often occurring sporadically due to early embryonic disruptions.</p>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">It is characterized by the presence of Homer Wright rosettes</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">It shows extensive necrosis with dystrophic calcification</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">It is associated with the presence of Flexner-Wintersteiner rosettes</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">It exhibits spindle-shaped tumor cells arranged in a storiform pattern</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old boy is brought to the pediatric ophthalmology clinic with a white pupil in his right eye noticed by his mother during a flash photograph. A clinical examination confirms the presence of a mass in the right eye, and further imaging reveals a mass consistent with retinoblastoma. An enucleation is performed, and histopathological examination of the specimen shows nests of malignant cells with scant cytoplasm, round to oval nuclei, and a high nuclear-to-cytoplasmic ratio. Which of the following statements best describes the histopathological findings seen in this case?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011179ed0354-03cb-4200-a27b-9bcc27743293.jpg\"></span></p>",
      "unique_key": "DT1296226",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296226,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Flexner-Wintersteiner rosettes</strong> are a hallmark of retinoblastoma, indicating differentiation towards photoreceptor cells. They consist of <strong>tumor cells arranged around a central lumen</strong>, reflecting retinal cell differentiation.</li>\n<li><strong>Other Histopathological Features:</strong>\n<ul>\n<li><strong>Nests of Malignant Cells</strong> with scant cytoplasm and high nuclear-to-cytoplasmic ratio.</li>\n<li><strong>Calcification</strong> may be seen, though not a defining feature.</li>\n</ul>\n</li>\n<li><strong>Histopathological Features:</strong>\n<ul>\n<li><strong>Nests of Malignant Cells:</strong> Composed of poorly differentiated neuroectodermal cells.</li>\n<li><strong>Flexner-Wintersteiner Rosettes:</strong> Classic histopathological finding, indicative of differentiation towards photoreceptor cells.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011166ea5f8b-24ad-4a1e-95ea-9ae2aceb380c.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111b5411835-d95e-4ea3-96ec-dcbe00867c87.jpg\"><br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111d1580094-4b42-4f97-bd38-6e859f27d2a6.jpg\">\n<p><strong>Additional Points on Retinoblastoma:</strong></p>\n<ul>\n<li><strong>Pathology:</strong> Tumor originates from <strong>immature retinal cells</strong> (retinoblasts).</li>\n<li><strong>Other Histological Findings:</strong> Small round blue cells, <strong>high mitotic index</strong>, areas of necrosis.</li>\n<li><strong>Spread:</strong> Can invade the optic nerve, <strong>choroid, and sclera</strong>, and metastasize.</li>\n<li><strong>Management:</strong> Includes <strong>enucleation</strong>, chemotherapy, and focal therapies (cryotherapy, laser).</li>\n</ul>\n<p><strong>Why Not Other Options:</strong></p>\n<ul>\n<li><strong>A) Homer Wright rosettes:</strong> Associated with <strong>neuroblastoma</strong>, not retinoblastoma; feature central fibrillary material.</li>\n<li><strong>B) Extensive necrosis with dystrophic calcification:</strong> Necrosis may occur, but <strong>rosettes are a classic feature</strong> in retinoblastoma histology.</li>\n<li><strong>D) Spindle-shaped tumor cells in a storiform pattern:</strong> This pattern is typical of <strong>sarcomas</strong> or fibrous tumors, not retinoblastoma.</li>\n</ul>\n<p><strong>Key Takeaways:</strong><br /> Retinoblastoma is the most common primary intraocular malignancy in children, with <strong>Flexner-Wintersteiner rosettes</strong> as a key histopathological feature, and is often linked to mutations in the <strong>RB1 gene</strong>.</p>",
      "correct_choice_id": 143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Enucleation of the affected eye</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic chemotherapy followed by focal therapy</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Systemic chemotherapy followed by focal therapy</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation with close follow-up</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 2-year-old girl is diagnosed with bilateral retinoblastoma after presenting with leukocoria in both eyes. The tumor is classified as Group D according to the International Classification of Retinoblastoma (ICRB), with the right eye showing a large mass extending to the optic nerve head. The parents are concerned about the treatment options and potential impact on her vision and overall health. Which of the following treatment modalities is considered the most appropriate for this child's condition?</span></p>",
      "unique_key": "DT1296229",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296229,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Systemic chemotherapy</strong>: Effective in <strong>reducing tumor size</strong> and <strong>controlling tumor spread</strong> in bilateral retinoblastoma, often using drugs like <strong>vincristine, etoposide, and carboplatin</strong>.</li>\n<li><strong>Focal therapy (laser or cryotherapy)</strong>: Applied after chemoreduction to <strong>target residual tumor</strong>, <strong>preserving visual potential</strong> in the less-affected eye.</li>\n<li><strong>Goal</strong>: This combined approach aims to <strong>avoid enucleation</strong> and <strong>minimize radiation exposure</strong>, especially in young children, who are at increased risk for radiation-induced secondary malignancies.</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111f7dd19f0-2267-454c-af1c-8f0692a2c129.jpg\">\n<p><strong>Why Not Other Options</strong></p>\n<ul>\n<li><strong>Enucleation (A)</strong>: Typically reserved for <strong>unilateral advanced tumors</strong> or cases unresponsive to other therapies; removing the eye with bilateral disease may <strong>compromise vision</strong> severely.</li>\n<li><strong>External Beam Radiation Therapy (C)</strong>: High risk of <strong>secondary cancers</strong> and <strong>ocular complications</strong> (e.g., cataracts, dry eye); generally avoided in young children unless all other treatments fail.</li>\n<li><strong>Observation with close follow-up (D)</strong>: Inappropriate for Group D retinoblastoma, which is considered <strong>high-risk for progression</strong> and requires active treatment.</li>\n</ul>\n<p><strong>Key Takeaways:</strong></p>\n<p>For Group D bilateral retinoblastoma, <strong>systemic chemotherapy followed by focal therapy</strong> is optimal to achieve <strong>tumor control</strong> and <strong>preserve vision</strong>. Other options like enucleation and radiation are used selectively to <strong>reduce long-term risks</strong> and focus on functional outcomes.</p>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Immediate surgical resection is the first-line treatment for all cases</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiation therapy is the primary treatment for optic nerve glioma in pediatric patients</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Chemotherapy is often used as the initial treatment for progressive optic nerve glioma in children</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation is recommended for all cases, as these tumors are typically asymptomatic</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old boy is referred to the ophthalmology clinic due to progressive vision loss in his right eye over the past six months. His mother reports that he has had difficulty in school, frequently squinting to read the blackboard. On examination, his best-corrected visual acuity is 20/200 in the left eye and 20/20 in the right eye. Fundoscopy reveals a pale optic disc in the left eye. An MRI of the brain shows a mass centered on the optic nerve, extending from the optic chiasm to the left globe. Which of the following statements regarding the management of this condition is most accurate?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011177dc6dd2-214a-4b15-9d94-18861eaaf0ba.jpg\"></span></p>",
      "unique_key": "DT1296231",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296231,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Chemotherapy</strong>: Considered the primary approach for <strong>progressive optic nerve gliomas</strong> in children, especially in cases associated with <strong>neurofibromatosis type 1 (NF1)</strong>. Commonly used agents include:\n<ul>\n<li><strong>Vincristine</strong>: Targets rapidly dividing cells.</li>\n<li><strong>Carboplatin</strong>: A platinum-based agent that works synergistically with vincristine to enhance tumor response.</li>\n</ul>\n</li>  \n<li><strong>Clinical Monitoring</strong>: Regular follow-ups and MRI imaging are crucial to assess tumor progression and response to chemotherapy, adjusting treatment as necessary.</li>\n<li><strong>Surgical Resection</strong>: While it can be effective in certain scenarios, surgery is often delayed until:\n<ul>\n<li>There is a <strong>clear visual impairment</strong> that cannot be managed through chemotherapy.</li>\n<li>The tumor causes significant <strong>mass effect</strong> or risks to surrounding structures.</li>\n</ul>\n</li>  \n<li><strong>Radiation Therapy</strong>: Typically reserved for:\n<ul>\n<li>Cases not responding to chemotherapy.</li>\n<li>Older children or adults, given the <strong>long-term neurocognitive risks</strong> in younger patients.</li>\n</ul>\n</li>  \n<li><strong>Observation</strong>: Appropriate for:\n<ul>\n<li>Tumors that are <strong>asymptomatic</strong> or stable, particularly in younger children where interventions may lead to adverse effects.</li>\n<li>Requires <strong>close follow-up</strong> to monitor for any signs of progression, including changes in visual acuity or the appearance of new symptoms.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Other Options</strong></p>\n<ul>\n<li><strong>Immediate surgical resection (A)</strong>: Not universally applicable; the risks of surgery must be weighed against the benefits, especially given the potential for <strong>optic nerve damage</strong>.</li>\n<li><strong>Radiation therapy (B)</strong>: While effective, its use in children is limited due to concerns over <strong>developmental impacts</strong> and potential for <strong>secondary cancers</strong> later in life.</li>\n<li><strong>Observation (D)</strong>: Inappropriate for symptomatic or progressive cases, as delayed intervention can result in irreversible vision loss or further complications.</li>\n</ul>\n<p><strong>Key Takeaways</strong></p>\n<p>Chemotherapy is the <strong>preferred initial treatment</strong> for progressive optic nerve gliomas in children, especially those associated with NF1. While surgery and radiation therapy play roles in specific cases, they are secondary to medical management to minimize risks and preserve vision. Regular monitoring is essential to adapt treatment based on tumor behavior and patient response.</p>",
      "correct_choice_id": 163,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinoblastoma</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital cataract</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">Coats' disease</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinal detachment</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-year-old girl is brought to the pediatric ophthalmology clinic with a chief complaint of a white reflection in her right eye, which her mother first noticed in photographs taken with a flash. The child is otherwise healthy and has no significant medical history. On examination, visual acuity is not reliably measurable due to her age, but fixation appears normal. Fundoscopy reveals a white mass behind the lens in the right eye. The left eye appears normal. Which of the following conditions is the most likely cause of leukocoria in this child?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011145a4e99b-ac42-4b10-880e-c421419f056c.jpg\"></span></p>",
      "unique_key": "DT1296233",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296233,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Retinoblastoma</strong>:\n<ul>\n<li><strong>Most common cause of leukocoria in children under 5.</strong></li>\n<li>Characteristic presentation includes a white mass behind the lens.</li>\n</ul>\n</li>  \n<li><strong>Congenital cataract</strong>:\n<ul>\n<li>Can cause leukocoria, but typically presents as lens opacity without a distinct mass.</li>\n<li>Often affects visual acuity more severely than retinoblastoma.</li>\n</ul>\n</li>  \n<li><strong>Coats' disease</strong>:\n<ul>\n<li>Usually presents with retinal exudates and vision loss.</li>\n<li>Less commonly associated with leukocoria in this age group.</li>\n</ul>\n</li>  \n<li><strong>Retinal detachment</strong>:\n<ul>\n<li>May cause leukocoria but is less likely without trauma or significant symptoms in this child.</li>\n</ul>\n</li>  \n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/2025011103275525-549c-441e-bcad-b40d7f10363f.jpg\">\n<p><strong>Why Not Others</strong>:</p>\n<ul>\n<li><strong>B)</strong> Congenital cataract: Opacity may not appear as a distinct mass behind the lens.</li>\n<li><strong>C)</strong> Coats' disease: Typically involves retinal vascular issues rather than a distinct mass.</li>\n<li><strong>D)</strong> Retinal detachment: Unlikely as the primary cause in a healthy child without trauma.</li>\n</ul>\n<p><strong>Key Takeaways</strong>:</p>\n<ul>\n<li><strong>Leukocoria</strong> indicates potential serious conditions in children; retinoblastoma is the most common cause.</li>\n<li><strong>Urgent evaluation</strong> by a pediatric ophthalmologist is essential for any child presenting with leukocoria.</li>\n<li><strong>Management</strong> may include imaging and treatment options like surgery or chemotherapy for retinoblastoma.</li>\n</ul>",
      "correct_choice_id": 171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">Neuroblastoma</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">Retinoblastoma</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">Orbital cellulitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 5-year-old boy is brought to the emergency department with a noticeable swelling in the left periorbital region. His mother reports that the swelling has increased in size over the past two months and that the child has experienced intermittent pain and redness in the eye. On examination, the child has proptosis of the left eye, and there is a palpable mass in the superior orbit. Visual acuity is 20/20 in the right eye and 20/30 in the left eye. CT scan of the orbits reveals an infiltrative mass involving the extraocular muscles and adjacent structures. Given this presentation, which of the following is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501116b026bd1-f7f1-4e8d-9cb6-cfa79388b3ec.jpg\"></span></p>",
      "unique_key": "DT1296236",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296236,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Rhabdomyosarcoma</strong>:\n<ul>\n<li><strong>Most Common Soft Tissue Sarcoma</strong>: Predominantly found in children, especially under 10 years of age.</li>\n<li><strong>Infiltrative Mass</strong>: Characterized by involvement of extraocular muscles, leading to symptoms like proptosis, strabismus, or vision loss.</li>\n<li><strong>Presentation</strong>: Often presents as a painless or mildly painful mass; can cause redness and intermittent pain due to pressure on surrounding structures.</li>\n<li><strong>Histological Variants</strong>: Includes embryonal (most common in the orbit), alveolar, pleomorphic, and myxoid variants.\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/20250111a1c8dce2-b934-41f9-baef-badb24f9f55f.jpg\">\n</li>\n</ul>\n</li>  \n<li><strong>Neuroblastoma</strong>:\n<ul>\n<li><strong>Origin</strong>: Derived from neural crest cells, primarily affecting the adrenal glands or sympathetic ganglia, with rare orbital involvement.</li>\n<li><strong>Symptoms</strong>: Typically presents with abdominal masses, systemic symptoms like fever, weight loss, or bone pain.</li>\n<li><strong>Less Likely in Orbit</strong>: While it can metastasize to the orbits, it usually presents with different systemic signs.</li>\n</ul>\n</li>\n<li><strong>Retinoblastoma</strong>:\n<ul>\n<li><strong>Intraocular Tumor</strong>: Usually presents with leukocoria and strabismus rather than a palpable mass.</li>\n<li><strong>Age Group</strong>: Commonly seen in children younger than 5 years; presents with vision changes, not typically proptosis as an initial sign.</li>\n</ul>\n</li>\n<li><strong>Orbital cellulitis</strong>:\n<ul>\n<li><strong>Infectious Process</strong>: Typically associated with fever, swelling, and redness, with pain on eye movement.</li>\n<li><strong>Absence of Palpable Mass</strong>: Generally does not present with a distinct mass; proptosis may occur, but with associated infectious symptoms.</li>\n</ul>\n</li>\n</ul>\n<p><strong>Why Not Others</strong>:</p>\n<ul>\n<li><strong>A)</strong> Neuroblastoma: Less likely due to primary abdominal association and typical systemic symptoms, not presenting primarily as an orbital mass.</li>\n<li><strong>C)</strong> Retinoblastoma: Primarily intraocular; while it can cause proptosis, it presents with other ocular symptoms, such as leukocoria.</li>\n<li><strong>D)</strong> Orbital cellulitis: Lacks the distinct palpable mass characteristic of rhabdomyosarcoma; more commonly presents with systemic infectious signs.</li>\n</ul>\n<p><strong>Key Takeaways</strong>:</p>\n<ul>\n<li><strong>Rhabdomyosarcoma</strong> is a critical diagnosis in children with orbital masses and proptosis, often requiring immediate attention.</li>\n<li><strong>Imaging</strong> (CT or MRI) is essential to evaluate the extent and characteristics of the mass; biopsy confirms the diagnosis.</li>\n<li><strong>Multimodal Treatment</strong>: Involves surgery, chemotherapy, and possibly radiation therapy; prognosis varies with tumor subtype and response to treatment.</li>\n</ul>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">Basal cell carcinoma</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">Squamous cell carcinoma</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Sebaceous gland carcinoma</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Chalazion</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 70-year-old woman presents to the ophthalmology clinic with a complaint of a painless, slowly enlarging mass on her right eyelid that has been present for several months. On examination, the mass appears as a firm, yellowish nodule on the upper eyelid margin, with associated subtle erythema of the surrounding skin. The patient reports that the lesion occasionally crusts over but has never been painful. There is no history of trauma or previous surgical procedures to the eyelid. Given this presentation, which of the following is the most likely diagnosis?<br><img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501111984ac4d-e4cb-4508-9400-59bd2dee9167.jpg\"></span></p>",
      "unique_key": "DT1296239",
      "question_audio": null,
      "question_video": null,
      "map_id": 1296239,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1
      ],
      "solution": "<ul>\n<li><strong>Sebaceous Gland Carcinoma</strong>:\n<ul>\n<li><strong>Typical Presentation</strong>: Commonly appears as a painless, firm, yellowish nodule on the eyelid, particularly the upper lid.</li>\n<li><strong>Characteristics</strong>: Often mistaken for a benign lesion like a chalazion; may have associated erythema and crusting due to irritation.</li>\n<li><strong>Demographics</strong>: Most commonly seen in older adults; may be aggressive with local invasion and recurrence.</li>\n</ul>\n</li>\n<li><strong>Basal Cell Carcinoma</strong>:\n<ul>\n<li><strong>Common Eyelid Malignancy</strong>: Typically presents as a pearly, translucent nodule with telangiectasia or ulceration.</li>\n<li><strong>Presentation Difference</strong>: Does not typically appear as a firm yellowish nodule.</li>\n</ul>\n</li>\n<li><strong>Squamous Cell Carcinoma</strong>:\n<ul>\n<li><strong>Presentation</strong>: Usually presents as a scaly, red patch or firm nodule; less common than sebaceous gland carcinoma on the eyelid.</li>\n<li><strong>Characteristics</strong>: More likely to show inflammatory changes and ulceration.</li>\n</ul>\n</li>\n<li><strong>Chalazion</strong>:\n<ul>\n<li><strong>Nature</strong>: A blockage of a meibomian gland, presenting as a painless swelling but usually not firm or yellowish.</li>\n<li><strong>Inflammatory Signs</strong>: Typically lacks surrounding erythema unless there is secondary inflammation.</li>\n</ul>\n</li>\n</ul>\n<img class=\"w-100\" style=\"height:auto; display:block; vertical-align:middle; border:0; \"src=\"https://d3d535v34tlady.cloudfront.net/V3/NEETPGMCQ/202501115a75e22a-f38e-4fc9-bd8d-8605e4df80d6.jpg\">\n<p><strong>Why Not Others</strong>:</p>\n<ul>\n<li><strong>A)</strong> Basal Cell Carcinoma: Typically presents with pearly or translucent characteristics, not as a firm yellowish nodule.</li>\n<li><strong>B)</strong> Squamous Cell Carcinoma: Less common on the eyelid and often shows more aggressive features like ulceration; does not match the presentation.</li>\n<li><strong>D)</strong> Chalazion: Generally presents as a painless swelling but lacks the firm yellowish appearance and associated erythema.</li>\n</ul>\n<p><strong>Key Takeaways</strong>:</p>\n<ul>\n<li><strong>Sebaceous Gland Carcinoma</strong>: A rare but aggressive malignancy that often masquerades as benign lesions; recognition is crucial for early intervention.</li>\n<li><strong>Diagnosis Confirmation</strong>: Requires biopsy for definitive diagnosis, revealing atypical sebaceous cells.</li>\n<li><strong>Imaging Studies</strong>: CT or MRI may assist in evaluating local invasion in advanced cases.</li>\n</ul>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}